Clinical Practices for Treating ICANS Following CAR T-Cell Therapy
The panel provides comprehensive insights on the treatment of ICANS following CAR T-cell therapy, highlighting the role of imaging, clinical trial data, and clinical pearls for community practices.
Video content above is prompted by the following questions:
- What do you consider best practices for the management of ICANS following CAR T-cell therapy?
- What are some strategies you can use to manage or mitigate ICANS in patients receiving CAR T-cell therapy?
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Recent Videos
Related Content
